Heart failure policy and practice in Europe
Heart failure policy and practice in Europe aims to support advocates with clear outline of policy issues and best practice in heart failure across 11 European countries.
Find out more
Heart failure and COVID‑19
With heart failure a high-risk pre-existing condition and heart damage a consequence of COVID-19, what does the pandemic mean for heart failure care?
Find out more
Heart failure and health system sustainability
A European case study outlining how prioritising heart failure can help to build resilient and sustainable healthcare systems.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
Thoughts from the front line: heart failure services during the COVID-19 pandemic
23 June 2021

In this guest blog post, heart failure nurse consultant Carys Barton shares the challenges faced and innovative solutions implemented at Imperial College Healthcare NHS Trust in London.

Read article
Latest
New French translation of The handbook of multidisciplinary and integrated heart failure care
7 June 2021

The Heart Failure Policy Network has launched a French translation of The handbook of multidisciplinary and integrated heart failure care.

Read article
Latest
Webinar recording: ‘Freedom from heart failure: reimagining cardiac services in England’
14 May 2021

Watch the full webinar ‘Freedom from heart failure: reimagining cardiac services in England’ which was co-hosted by the Heart Failure Policy Network (HFPN) and the British Society for Heart Failure (BSH).

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.